Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations
Carregando...
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2013
Editora
SAGE PUBLICATIONS LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
LUPUS, v.22, n.7, p.744-749, 2013
Resumo
Epidemiological studies with systemic lupus erythematosus (SLE) patients have been reported worldwide but, until now, a large evaluation had not been performed in Brazil. Therefore, we determined the clinical and immunological features of 888 SLE patients followed at our service from 2008 to 2012. The mean age at SLE onset and the mean disease duration were 29.9 +/- 9.5 years old and 14.5 +/- 8.4 years, respectively. A predominance of female gender (91.9%) and Caucasian ethnicity (69.9%) were observed. Cumulative mucocutaneous manifestations (90.7%) were most commonly identified (malar rash (83.2%), photosensitivity (76.9%)) followed by articular (87.4%), hematological (44.0%) and renal (36.9%) involvements. Antinuclear antibody was detected in all patients, followed by anti-dsDNA (35.1%), anti-Sm (21.8%) and anti-ribosomal P protein antibodies (19.8%). Additional comparison of clinical and laboratory features between genders revealed that malar rash was observed more in female SLE patients (84.5% vs. 69.4%, p = 0.001). Male lupus patients presented a higher frequency of anti-dsDNA (45.8% vs. 34.2%, p = 0.047) and a trend of more nephritis (47.2% vs. 36.0%, p = 0.059). In conclusion, we identified a high prevalence of mucocutaneous manifestations in this Brazilian SLE cohort compared to other countries, mainly malar rash that was most commonly observed in female patients. Anti-dsDNA and other specific SLE autoantibodies were also identified in a higher frequency, predominantly in the male gender.
Palavras-chave
Anti-DNA, autoantibody, gender, malar rash, systemic lupus erythematosus
Referências
- Al Arfaj AS, 2009, LUPUS, V18, P465, DOI 10.1177/0961203308100660
- Al-Maini MH, 2003, RHEUMATOL INT, V23, P186, DOI 10.1007/s00296-003-0303-6
- AlSaleh J, 2008, LUPUS, V17, P62, DOI 10.1177/0961203307084297
- Andrade RM, 2007, ARTHRITIS RHEUM, V56, P622, DOI 10.1002/art.22375
- Bertoli AM, 2008, ANN RHEUM DIS, V67, P500, DOI 10.1136/ard.2007.076059
- BLANCO FJ, 1995, REV CLIN ESP, V195, P534
- BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503
- BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
- Burling F, 2007, LUPUS, P16830
- CERVERA R, 1993, MEDICINE, V72, P113
- CHAHADE WH, 1995, LUPUS, V4, P100, DOI 10.1177/096120339500400204
- Cooper GS, 1998, ARTHRITIS RHEUM, V41, P1714, DOI 10.1002/1529-0131(199810)41:10<1714::AID-ART3>3.0.CO;2-U
- ELKON KB, 1984, J IMMUNOL, V132, P2350
- GHARAVI AE, 1987, ANN RHEUM DIS, V46, P1, DOI 10.1136/ard.46.1.1
- Ghirardello A, 2000, ANN RHEUM DIS, V59, P975, DOI 10.1136/ard.59.12.975
- Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
- Houman MH, 2004, LUPUS, V13, P204, DOI 10.1191/0961203303lu530xx
- Kiss E, 2007, CLIN REV ALLERG IMMU, V32, P37, DOI 10.1007/BF02686080
- KURATA N, 1976, ARTHRITIS RHEUM, V19, P574, DOI 10.1002/art.1780190309
- Lau CS, 2006, LUPUS, V15, P715, DOI 10.1177/0961203306072311
- Mahler M, 2006, CLIN VACCINE IMMUNOL, V13, P77, DOI 10.1128/CVI.13.1.77-83.2006
- MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608
- Mok CC, 2003, LUPUS, V12, P717, DOI 10.1191/0961203303lu451xx
- PISTINER M, 1991, SEMIN ARTHRITIS RHEU, V21, P55, DOI 10.1016/0049-0172(91)90057-7
- Pons-Estel BA, 2004, MEDICINE, V83, P1, DOI 10.1097/01.md.0000104742.42401.c2
- SAMANTA A, 1991, ANN RHEUM DIS, V50, P490, DOI 10.1136/ard.50.7.490
- Santos MJ, 2007, ACTA REUMATOL PORT, V32, P153
- Senna Erika Rodrigues, 2004, Journal of Rheumatology, V31, P594
- Tan EM, 1980, MANUAL CLIN IMMUNOLO, P866
- Tan TC, 2012, J RHEUMATOL, V39, P759, DOI 10.3899/jrheum.111061
- Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359
- Vila LM, 1999, LUPUS, V8, P279, DOI 10.1191/096120399678847803
- Vila LM, 2004, RHEUMATOLOGY, V43, P358, DOI 10.1093/rheumatology/keh048
- Vilá L M, 1999, P R Health Sci J, V18, P89
- Vilar MJP, 2002, LUPUS, V11, P528, DOI 10.1191/0961203302lu244xx